Posted September 23, 2018 08:01:03In the U.S., people with chronic conditions like chronic fatigue syndrome (CFS), chronic pain and rheumatoid arthritis are at greater risk for developing an autoimmune disorder, which is the body’s response to the presence of an autoimmune disease.

Researchers at the Yale University School of Medicine in New Haven, Connecticut, recently discovered that certain types of arthritis drugs and injections could be interfering with the immune system.

A new study published in the Journal of Clinical Endocrinology & Metabolism found that the type of drugs, such as arborostatin-A, can disrupt the production of interferon-alpha (IFN-alpha), a protein that helps the immune response against invading foreign invaders.

According to the study, people with CFS and chronic pain had significantly lower levels of IFN-α.

The researchers also found that some of the drugs and vaccines in question, including the two drugs used in the study that were approved for use in the U, also interfered with IFN production.

The new study did not determine whether the drugs affected patients’ IFN levels in any way.

But researchers say that the finding does not mean that the drugs themselves should not be used.

“These findings do not necessarily indicate that the products that are approved for patients with chronic pain should not also be used for people with rheumatic diseases or chronic fatigue,” Dr. Jennifer Kallen, one of the study authors, said in a press release.

Kallen and her colleagues looked at the results of a study involving the use of the two medicines atrial fibrillation drugs arboroplastin (Arpa) and voriconazole (Valium) to treat people with MS.

The drugs were given to patients with MS who had experienced high levels of symptoms and fatigue, which often included joint pain.

After two months, the researchers found that patients who had taken Arpa had significantly reduced levels of interleukin-2 (IL-2), a cytokine that helps to fight off infections.

IL-2 is one of several molecules that are part of the immune reaction that the immune systems use to help fight off invading pathogens.

In the study’s follow-up phase, the scientists also found a reduction in IFN response in patients who took the drugs.

The patients who were given the drugs also showed a significantly lower number of B-cells in their blood.

The study is the first to show that certain drugs can interfere with the body, the authors wrote.

“The finding that patients taking certain types [of arthritis drugs] have reduced levels [of interleucin-1 and IL-6] may be the first evidence that some drugs interfere with interleuinf-1, IL-1β and other cytokines that are produced in the immune cells, which are involved in regulating the immune responses against invading pathogens,” said study co-author and medical director of Yale University’s department of medicine, Dr. Joseph P. Zukerman.

The authors wrote that this study is only one of a number of studies to show how some arthritis drugs interfere, and they encourage the public to call the FDA if they have concerns.

If you or anyone you know needs treatment for a medical condition, call the UPMC-New Haven emergency line at 1-800-822-6331.